Novateor Research Laboratories Ltd Stock Price Today (NSE: NOVATEOR)
Fundamental Score
Novateor Research Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Novateor Research Laboratories Ltd share price today is ₹32.85, up +0.00% on NSE/BSE as of 17 June 2026. Novateor Research Laboratories Ltd (NOVATEOR) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹15.19 (Cr). The 52-week high for NOVATEOR share price is ₹57.50 and the 52-week low is ₹20.08. At a P/E ratio of 506.33x, NOVATEOR is currently trading above its industry average P/E of 50.39x. The company has a Return on Equity (ROE) of 0.83% and a debt-to-equity ratio of 0.06.
Novateor Research Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance
Novateor Research Laboratories Ltd share price chart: 5.25% return over the past month. 52-week high ₹57.50, 52-week low ₹20.08.
Novateor Research Laboratories Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 0.00 (Cr) |
Novateor Research Laboratories Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | +0.00% | |
| ₹31.21 | ₹32.85 | ₹31.21 | ₹32.85 | +5.25% | |
| ₹31.21 | ₹31.21 | ₹31.21 | ₹31.21 | +0.00% | |
| ₹31.21 | ₹31.21 | ₹31.21 | ₹31.21 | +0.00% | |
| ₹32.85 | ₹32.85 | ₹31.21 | ₹31.21 | -4.99% | |
| ₹24.00 | ₹34.50 | ₹24.00 | ₹32.85 | +36.88% | |
| ₹25.10 | ₹25.10 | ₹20.08 | ₹24.00 | -4.38% | |
| ₹26.00 | ₹26.00 | ₹25.10 | ₹25.10 | -3.46% | |
| ₹24.50 | ₹27.00 | ₹23.00 | ₹26.00 | +6.12% | |
| ₹30.16 | ₹32.90 | ₹24.00 | ₹24.50 | -18.77% | |
| ₹51.77 | ₹51.77 | ₹31.60 | ₹33.39 | -35.50% | |
| ₹54.63 | ₹54.63 | ₹49.31 | ₹51.77 | -5.24% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Novateor Research Laboratories Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Novateor Research Laboratories Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NOVATEOR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Revenue Growth (212.66%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (48.11% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (58.49% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (58.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (50.90%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (0.83%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.69%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-21.36%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 506.33x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-166.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (1.60x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-5.20 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Novateor Research Laboratories Ltd vs Personal Care Peers
Peer Comparison - Personal Care
Compare Novateor Research Laboratories Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Novateor Research Laboratories LtdNovateor Resear...Selected✓ NOVATEOR • 542771 | 44/100 | ₹32.85₹33 | ₹15.19₹15.19 | 506.33Average 506.3 Average | 0.83%Poor 0.83% Poor | 1.69%Poor 1.69% Poor | 0.06Excellent 0.1 Excellent | 58.49%Excellent 58.49% Excellent | 48.11%Excellent 48.11% Excellent | 0.00% |
Godrej Consumer Products LtdGodrej Consumer... GODREJCP • 532424 | 42.9/100 | ₹1044.40₹1044 | ₹115504.75₹115504.75 | 61.35Average 61.4 Average | 15.21%Good 15.21% Good | 19.21%Good 19.21% Good | 0.34Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 7.70%Good 7.70% Good | 1.33% |
Dabur India LtdDabur India Ltd... DABUR • 500096 | 45.3/100 | ₹445.45₹445 | ₹91407.05₹91407.05 | 50.53Average 50.5 Average | 17.04%Good 17.04% Good | 20.24%Excellent 20.24% Excellent | 0.12Excellent 0.1 Excellent | 3.01%Average 3.01% Average | 7.66%Good 7.66% Good | 1.55% |
Colgate Palmolive India LtdColgate Palmoli... COLPAL • 500830 | 53.3/100 | ₹2087.40₹2087 | ₹58477.58₹58477.58 | 44.10Average 44.1 Average | 81.19%Excellent 81.19% Excellent | 105.34%Excellent 105.34% Excellent | 0.04Excellent 0.0 Excellent | 11.96%Good 11.96% Good | 5.95%Good 5.95% Good | 2.37% |
Procter & Gamble Hygiene LimitedProcter & Gambl... PGHH • 500459 | 49.3/100 | ₹10115.00₹10115 | ₹41537.66₹41537.66 | 50.25Average 50.3 Average | 75.67%Excellent 75.67% Excellent | 103.79%Excellent 103.79% Excellent | 0.00Excellent 0.0 Excellent | 8.44%Good 8.44% Good | 2.75%Average 2.75% Average | 0.86% |
Gillette India LtdGillette India ... GILLETTE • 507815 | 54.7/100 | ₹8273.50₹8274 | ₹27967.94₹27967.94 | 48.73Average 48.7 Average | 41.62%Excellent 41.62% Excellent | 56.06%Excellent 56.06% Excellent | 0.00Excellent 0.0 Excellent | 10.45%Good 10.45% Good | 3.72%Average 3.72% Average | 1.31% |
Emami LtdEmami Ltd... EMAMILTD • 531162 | 57.2/100 | ₹400.45₹400 | ₹22959.79₹22959.79 | 30.46Average 30.5 Average | 30.18%Excellent 30.18% Excellent | 32.42%Excellent 32.42% Excellent | 0.02Excellent 0.0 Excellent | 21.30%Excellent 21.30% Excellent | 7.49%Good 7.49% Good | 1.52% |
Cupid LtdCupid Ltd... CUPID • 530843 | 32.5/100 | ₹128.90₹129 | ₹9372.27₹9372.27 | 151.83Average 151.8 Average | 12.89%Average 12.89% Average | 17.10%Good 17.10% Good | 0.07Excellent 0.1 Excellent | 0.89%Average 0.89% Average | 2.70%Average 2.70% Average | 0.00% |
Honasa Consumer LtdHonasa Consumer... HONASA • 544014 | 51.3/100 | ₹419.95₹420 | ₹9315.44₹9315.44 | 74.86Average 74.9 Average | 5.51%Poor 5.51% Poor | 7.44%Poor 7.44% Poor | 0.09Excellent 0.1 Excellent | 16.54%Excellent 16.54% Excellent | 76.22%Excellent 76.22% Excellent | 0.00% |
Bajaj Consumer Care LtdBajaj Consumer ... BAJAJCON • 533229 | 58.3/100 | ₹560.75₹561 | ₹3635.38₹3635.38 | 26.63Average 26.6 Average | 15.70%Good 15.70% Good | 19.06%Good 19.06% Good | 0.03Excellent 0.0 Excellent | -7.53%Poor -7.53% Poor | 2.51%Average 2.51% Average | 0.00% |
Anondita MediAnondita Medi... ANONDITA • | 33.7/100 | ₹1013.25₹1013 | ₹1191.73₹1191.73 | 51.90Average 51.9 Average | — — | — — | 0.43Excellent 0.4 Excellent | — — | — — | 0.00% |
Top Personal Care Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Consumer Products Ltd share price115504.75 Cr
- Dabur India Ltd share price91407.05 Cr
- Colgate Palmolive India Ltd share price58477.58 Cr
- Procter & Gamble Hygiene Limited share price41537.66 Cr
- Gillette India Ltd share price27967.94 Cr
Novateor Research Laboratories Ltd Quarterly Performance
Latest quarterly metrics for NOVATEOR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
212.66%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-166.67%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
48.11%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
58.49%
Compounded annual net profit growth over 5 years
Novateor Research Laboratories Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NOVATEOR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Novateor Research Laboratories Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Novateor Research Laboratories Ltd (NOVATEOR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Novateor Research Laboratories Ltd
About NOVATEOR (Novateor Research Laboratories Ltd)
Novateor Research Laboratories Ltd is an innovative force in the personal care sector, dedicated to revolutionizing daily hygiene routines with cutting-edge formulations and user-c...entric designs. We specialize in oral care, crafting meticulously designed products that extend beyond basic cleaning to promote overall well-being. Our team of experts blends scientific rigor with a deep understanding of consumer needs to develop solutions that are both effective and enjoyable to use. From revolutionary teeth whitening technologies to refreshingly unique mouthwashes, Novateor is committed to delivering products that empower individuals to confidently embrace their best selves. We strive to redefine personal care, one innovative product at a time. At the heart of Novateor's philosophy is a dedication to quality and accessibility. We meticulously source the finest ingredients and employ state-of-the-art manufacturing processes to ensure that our products meet the highest standards of safety and efficacy. We believe that superior personal care should be available to everyone, which is why we strive to offer a range of solutions that cater to diverse needs and preferences. Beyond product development, Novateor fosters strong relationships with dental professionals and cosmetic specialists, ensuring that our innovations are seamlessly integrated into their practices and readily available to the public. Our commitment extends to education and awareness, empowering individuals with the knowledge to make informed decisions about their personal care routines. Novateor envisions a future where personal care is an integral part of a holistic approach to health and well-being. We are committed to expanding our research and development efforts, continuously exploring new technologies and formulations that push the boundaries of what is possible. With a focus on sustainability and ethical sourcing, we strive to minimize our environmental impact and contribute to a more responsible future for the personal care industry. Under the SmiloShine brand, we bring the light back in people's lives with a brighter smile. Novateor is dedicated to remaining at the forefront of innovation, empowering individuals to confidently embrace a healthier, more radiant future.
Company Details
Key Leadership
Latest News
NOVATEOR Share Price: Frequently Asked Questions
What is the current share price of Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd (NOVATEOR) trades at ₹32.85 on NSE and BSE. Market cap ₹15.19 (Cr). Educational data only.
What is the P/E ratio of Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd has a P/E of 506.33x vs industry average 50.39x.
What is the Bull Run score for Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd has a Bull Run score of 44/100 based on 25+ financial parameters.
Does Novateor Research Laboratories Ltd pay dividends?
Novateor Research Laboratories Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd has ROE of 0.83%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Novateor Research Laboratories Ltd?
Novateor Research Laboratories Ltd has debt-to-equity of 0.06.
Is Novateor Research Laboratories Ltd a good investment?
Bull Run gives Novateor Research Laboratories Ltd a score of 44/100. This is not investment advice — consult a SEBI-registered advisor.